Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-10 Option Award |
2025-04-11 4:09 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Operating Officer |
5,967 | $0 | 48,428 (Direct) |
View |
| 2025-04-10 Tax Withholding |
2025-04-11 4:09 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Operating Officer |
1,454 | $6.91 | 48,428 (Direct) |
View |
| 2025-02-13 Tax Withholding |
2025-02-14 4:27 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Operating Officer |
822 | $7.18 | 43,915 (Direct) |
View |
| 2025-01-16 Option Award |
2025-01-21 4:11 pm |
N/A 2035-01-16 |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Operating Officer |
60,000 | $0 | 84,737 (Direct) |
View |
| 2024-11-01 Option Award |
2024-11-14 4:42 pm |
N/A 2034-11-01 |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Operating Officer |
18,750 | $0 | 37,237 (Direct) |
View |
| 2024-08-05 Tax Withholding |
2024-08-07 4:04 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer |
4,755 | $8.96 | 18,487 (Direct) |
View |
| 2024-08-05 Option Award |
2024-08-07 4:04 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer |
16,200 | $0 | 18,487 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 5:02 pm |
N/A 2034-02-13 |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer |
40,500 | $0 | 46,430 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 4:46 pm |
N/A 2033-02-13 |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer |
20,900 | $0 | 20,900 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:10 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer |
6,750 | $0 | 5,260 (Direct) |
View |
| 2023-02-03 Tax Withholding |
2023-02-07 4:10 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Business Officer |
2,119 | $44.16 | 5,260 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:02 pm |
N/A 2032-06-16 |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Commercial Officer |
9,500 | $0 | 9,500 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:43 pm |
N/A 2032-02-11 |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Commercial Officer |
11,400 | $0 | 11,400 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-04 4:10 pm |
N/A 2031-10-01 |
Sage Therapeutics Inc. | SAGE | Benecchi Christopher Chief Commercial Officer |
45,000 | $0 | 45,000 (Direct) |
View |